Ignite Creation Date:
2024-05-06 @ 6:31 PM
Last Modification Date:
2024-10-26 @ 2:49 PM
Study NCT ID:
NCT05690971
Status:
RECRUITING
Last Update Posted:
2023-10-03
First Post:
2023-01-10
Brief Title:
Psychosocial Mobile App for Chronic Graft-Versus-Host Disease
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Study Overview
Official Title:
Randomized Controlled Trial of a Psychosocial Mobile Application App to Promote Coping for Patients With Chronic Graft-Versus-Host Disease GVHD
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research study is to see whether a psychosocial mobile app called Horizons is effective at improving quality of life symptom burden psychological distress and coping in patients living with chronic graft-versus host disease GVHD
Detailed Description:
Frequently patients living with chronic GVHD experience physical and emotional symptoms during the course of illness that impacts their quality of life Patients also often report difficulty managing many of the tasks they need to do to manage their chronic GVHD They also frequently have a lot of questions about chronic GVHD and the expected trajectory of this illness
The purpose of this research study is to see whether a psychosocial mobile app called Horizons is effective at improving quality of life symptom burden and psychological distress in patients with chronic GVHD
This study will randomly assign participants to either receiving Horizons plus usual care or usual care alone
Enrolled participants will be on the research study for up to sixteen weeks and it is expected that about 120 people will take part in this research study
The Leukemia and Lymphoma Society is supporting this research by providing funding
The purpose of this research study is to see whether a psychosocial mobile app called Horizons is effective at improving quality of life symptom burden and psychological distress in patients with chronic GVHD
This study will randomly assign participants to either receiving Horizons plus usual care or usual care alone
Enrolled participants will be on the research study for up to sixteen weeks and it is expected that about 120 people will take part in this research study
The Leukemia and Lymphoma Society is supporting this research by providing funding
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None